poly(N-p-vinylbenzyl-maltonamide)

structure in first source

Also Known As:

PVMA

Networked: 3 relevant articles (1 outcomes, 2 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Carbohydrates: 22023
- Polysaccharides: 15383
  - Oligosaccharides: 3566
    - Disaccharides: 990
      - Maltose: 285
        poly(N-p-vinylbenzyl-maltonamide): 3
  - Glucans: 1624
    - Maltose: 285
      - poly(N-p-vinylbenzyl-maltonamide): 3
- Sugars: 11126
  - Disaccharides: 990
    - Maltose: 285
      - poly(N-p-vinylbenzyl-maltonamide): 3
Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Benzene Derivatives: 17
        Benzylidene Compounds: 10
        Styrenes: 6
        Styrene: 559
        Polystyrenes: 897
        poly(N-p-vinylbenzyl-maltonamide): 3
Macromolecular Substances: 97
- Polymers: 13051
  - Plastics: 13104
    - Polystyrenes: 897
      - poly(N-p-vinylbenzyl-maltonamide): 3
Biomedical and Dental Materials
- Polymers: 13051
  - Plastics: 13104
    - Polystyrenes: 897
      - poly(N-p-vinylbenzyl-maltonamide): 3
Technology, Industry, and Agriculture
- Manufactured Materials
  - Biomedical and Dental Materials
    - Polymers: 13051
      - Plastics: 13104
        Polystyrenes: 897
        poly(N-p-vinylbenzyl-maltonamide): 3

Experts

1.	Diao, Dingwei: 1 article (01/2020)
2.	Huang, Yi: 1 article (01/2020)
3.	Li, Song: 1 article (01/2020)
4.	Luo, Zhangyi: 1 article (01/2020)
5.	Ma, Weina: 1 article (01/2020)
6.	Minnigh, Margaret Beth: 1 article (01/2020)
7.	Oberly, Patrick J: 1 article (01/2020)
8.	Poloyac, Samuel M: 1 article (01/2020)
9.	Sun, Jingjing: 1 article (01/2020)
10.	Xie, Wen: 1 article (01/2020)

Related Diseases

1.	Neoplasms (Cancer) 01/01/2020 - "In addition, codelivery of TAM via POEG-co-PVDSAHA micelles led to significantly improved antitumor efficacy in 4T1.2 tumor model compared with other groups such as combination of free SAHA and TAM and TAM-loaded POEG-co-PVMA micelles. "
2.	Emphysema 10/01/2018 - "Measures of both pectoralis and paravertebral erector spinae muscle cross-sectional area (PMA and PVMA, respectively) as well as emphysema on chest computed tomography (CT) scans were performed in 3705 current and former at-risk smokers (≥10 pack-years) aged 45-80 years enrolled into the COPDGene Study between 2008 and 2013. " 10/01/2018 - "At-risk smokers in the lowest (vs. highest) sex-specific quartile of PMA but not PVMA had 84% higher risk of death in adjusted models for demographics, smoking, dyspnea, comorbidities, exercise capacity, lung function, emphysema on CT, and coronary artery calcium content (hazard ratio [HR] 1.85 95% Confidence interval [1.14-3.00] P = 0.01). "
3.	Acquired Immunodeficiency Syndrome (AIDS) 01/01/2018 - "Demonstrating the utility of the assay, we employed the PVMA to assess vaccine interference in the setting of a candidate vaccine, using the infant HIV vaccines from the completed Pediatric AIDS Clinical Trials Group (PACTG) protocols 230 and 326 as examples. "
4.	Whooping Cough (Pertussis) 01/01/2018 - "To facilitate the assessment of inter-vaccine interference, we developed a pediatric vaccine multiplex assay (PVMA) to simultaneously measure antibodies against vaccines commonly administered to infants, including hepatitis B, Haemophilus influenzae type B, diphtheria, tetanus, pertussis, rubella, and respiratory syncytial virus (RSV). "
5.	Tetanus 01/01/2018 - "To facilitate the assessment of inter-vaccine interference, we developed a pediatric vaccine multiplex assay (PVMA) to simultaneously measure antibodies against vaccines commonly administered to infants, including hepatitis B, Haemophilus influenzae type B, diphtheria, tetanus, pertussis, rubella, and respiratory syncytial virus (RSV). "

Related Drugs and Biologics

1.	Micelles
2.	AIDS Vaccines
3.	Vaccines
4.	Calcium
5.	Antibodies